Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melhem Solh

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
A prognostic index for survival among mechanically ventilated hematopoietic cell transplant recipientsMelhem Solh, Sanjay Oommen, Rachel Isaksson Vogel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2019
Fludarabine and Total-Body Irradiation Conditioning before Ablative Haploidentical Transplantation: Long-Term Safety and EfficacyScott R Solomon, Melhem Solh, Xu Zhang, et al.
Blood Advances|August 16, 2020
CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapyBicky Thapa, Paolo F Caimi, Kirit M Ardeshna, et al.
Transplantation and Cellular Therapy|March 29, 2024
Immunosuppression-Free Status at 1 Year after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideMelhem Solh, Asad Bashey, Xu Zhang, et al.
Bone Marrow Transplantation|September 19, 2019
Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant programScott R Solomon, Melhem Solh, Katelin C Jackson, et al.
Blood Advances|March 24, 2023
Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donorsAsad Bashey, Xu Zhang, Lawrence E Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2017
Current Graft-versus-Host Disease-Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic TransplantScott R Solomon, Connie Sizemore, Xu Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Factors Predicting Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single CenterMelhem Solh, Xu Zhang, Katelin Connor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 3, 2017
Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite EndpointMelhem Solh, Xu Zhang, Katelin Connor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2016
Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute LeukemiaScott R Solomon, Connie A Sizemore, Xu Zhang, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
A prognostic index for survival among mechanically ventilated hematopoietic cell transplant recipientsMelhem Solh, Sanjay Oommen, Rachel Isaksson Vogel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2019
Fludarabine and Total-Body Irradiation Conditioning before Ablative Haploidentical Transplantation: Long-Term Safety and EfficacyScott R Solomon, Melhem Solh, Xu Zhang, et al.
Blood Advances|August 16, 2020
CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapyBicky Thapa, Paolo F Caimi, Kirit M Ardeshna, et al.
Transplantation and Cellular Therapy|March 29, 2024
Immunosuppression-Free Status at 1 Year after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideMelhem Solh, Asad Bashey, Xu Zhang, et al.
Bone Marrow Transplantation|September 19, 2019
Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant programScott R Solomon, Melhem Solh, Katelin C Jackson, et al.
Blood Advances|March 24, 2023
Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donorsAsad Bashey, Xu Zhang, Lawrence E Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2017
Current Graft-versus-Host Disease-Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic TransplantScott R Solomon, Connie Sizemore, Xu Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Factors Predicting Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single CenterMelhem Solh, Xu Zhang, Katelin Connor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 3, 2017
Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite EndpointMelhem Solh, Xu Zhang, Katelin Connor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2016
Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute LeukemiaScott R Solomon, Connie A Sizemore, Xu Zhang, et al.
Pageof 11